← Back to Clinical Trials
Recruiting NCT07440849

NCT07440849 Effects of Core Stability and Pelvic Clock Exercises in Sacroiliac Joint Dysfunction

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07440849
Status Recruiting
Phase
Sponsor Riphah International University
Condition Sacroiliac Joint Dysfunction
Study Type INTERVENTIONAL
Enrollment 50 participants
Start Date 2024-12-01
Primary Completion 2026-07-01

Eligibility & Interventions

Sex Female only
Min Age 25 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
core stability exercisespelvic clock exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 50 participants in total. It began in 2024-12-01 with a primary completion date of 2026-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The study will be a randomized control trial and will be conducted in DHQ and Sadiq Hospital in Sargodha District. This study will be completed in time duration of 10 months after the approval of synopsis. Nonprobability convenience sampling technique will be used and 50 participants will be recruited in study after randomization. The subjects will be divided into two groups. Group A(Experimental) will receive core stability and pelvic clock exercises with baseline treatment while Group B(Control) will receive only core stability exercises after baseline treatment. The tools that will be used are Numeric Pain Rating Scale (NPRS), Oswestry Disability index (ODI) and WHOQOL-BREF. Treatment have duration of 8 weeks with 3 sessions per week and an hour per session is requires. After data collection, data will be analyzed by using SPSS version 26.

Eligibility Criteria

Inclusion Criteria: * Vaginal delivery * Primiparous women * Pain intensity greater than 6 on the Numerical Pain Rating Scale (NPRS) * Positive responses to at least three physical provocation tests suggestive of sacroiliac joint dysfunction Exclusion Criteria: * Participants were excluded from the study if they had any of the following conditions: * Previous history of trauma * Musculoskeletal disorders (e.g., coccydynia, impingement syndrome) * Postpartum depression * Disc bulge or degeneration

Contact & Investigator

Central Contact

imran amjad

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

adeela arif, t-DPT

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07440849 clinical trial?

This trial is open to female participants only, aged 25 Years or older, up to 35 Years, studying Sacroiliac Joint Dysfunction. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07440849 currently recruiting?

Yes, NCT07440849 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07440849 trial being conducted?

This trial is being conducted at Sargodha, Pakistan.

Who is sponsoring the NCT07440849 clinical trial?

NCT07440849 is sponsored by Riphah International University. The principal investigator is adeela arif, t-DPT at Riphah International University. The trial plans to enroll 50 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology